MARKET

SESN

SESN

Sesen Bio, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5656
-0.0493
-8.02%
After Hours: 0.5300 -0.0356 -6.29% 19:45 03/27 EDT
OPEN
0.6200
PREV CLOSE
0.6149
HIGH
0.6500
LOW
0.5320
VOLUME
1.15M
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
0.3700
MARKET CAP
62.21M
P/E (TTM)
-0.4678
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SESN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SESN stock price target is 3.417 with a high estimate of 5.00 and a low estimate of 2.250.

EPS

SESN News

More
  • Edited Transcript of SESN earnings conference call or presentation 16-Mar-20 12:00pm GMT
  • Thomson Reuters StreetEvents · 4d ago
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38
  • Sesen Bio EPS misses by $0.24
  • seekingalpha · 03/16 16:02
  • Sesen Bio's (SESN) CEO Thomas Cannell on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/16 15:41

Industry

Biotechnology & Medical Research
-2.44%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About SESN

Sesen Bio, Inc., formerly Eleven Biotherapeutics, Inc., is a late-stage clinical company that provides targeted protein therapeutics (TPT) platform. The Company is focused on developing antibody-drug conjugate (ADC) therapies for the treatment of cancer. Its product pipeline includes Vicinium, Vicinium in combination with checkpoint inhibator, durvalumab, and VB6-845d. The Company’s lead program, Vicinium, is a fusion protein in Phase III development for the treatment of non-muscle invasive bladder cancer (NMIBC). It targets epithelial cell adhesion molecule (EpCAM) antigens on the surface of tumor cells to deliver a potent cytotoxin, Pseudomonas Exotoxin A (ETA) directly to cancer cells.
More

Webull offers kinds of Sesen Bio Inc stock information, including NASDAQ:SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions.